Mercer Global Advisors
WST icon

Mercer Global Advisors’s West Pharmaceutical WST Stock Holding History

Mercer Global Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.71M Buy
10,331
+3,830
+59% +$1.17M ﹤0.01% 1016
2026
Q1 		$1.63M Sell
6,501
-2,128
-25% -$529K ﹤0.01% 1295
2025
Q4 		$2.37M Buy
8,629
+509
+6% +$139K ﹤0.01% 1031
2025
Q3 		$2.13M Buy
8,120
+5,707
+237% +$1.39M ﹤0.01% 1010
2025
Q2 		$528K Buy
2,413
+560
+30% +$120K ﹤0.01% 1547
2025
Q1 		$415K Sell
1,853
-256
-12% -$70.6K ﹤0.01% 1577
2024
Q4 		$691K Sell
2,109
-1,028
-33% -$324K ﹤0.01% 1275
2024
Q3 		$941K Buy
3,137
+626
+25% +$192K ﹤0.01% 1041
2024
Q2 		$827K Sell
2,511
-23
-0.9% -$8.13K ﹤0.01% 1058
2024
Q1 		$1M Sell
2,534
-260
-9% -$96.2K ﹤0.01% 964
2023
Q4 		$984K Buy
2,794
+277
+11% +$98K ﹤0.01% 984
2023
Q3 		$944K Sell
2,517
-232
-8% -$89.7K ﹤0.01% 967
2023
Q2 		$1.05M Sell
2,749
-62
-2% -$22.1K ﹤0.01% 934
2023
Q1 		$974K Buy
2,811
+641
+30% +$187K ﹤0.01% 923
2022
Q4 		$511K Sell
2,170
-42
-2% -$9.95K ﹤0.01% 1193
2022
Q3 		$544K Sell
2,212
-247
-10% -$75.2K ﹤0.01% 1095
2022
Q2 		$744K Sell
2,459
-1,284
-34% -$418K ﹤0.01% 966
2022
Q1 		$1.54M Sell
3,743
-405
-10% -$159K 0.01% 733
2021
Q4 		$1.95M Buy
4,148
+170
+4% +$73.2K 0.01% 633
2021
Q3 		$1.69M Buy
3,978
+1,983
+99% +$836K 0.01% 669
2021
Q2 		$716K Buy
1,995
+119
+6% +$39.3K 0.01% 976
2021
Q1 		$529K Sell
1,876
-241
-11% -$69K ﹤0.01% 1063
2020
Q4 		$600K Buy
2,117
+818
+63% +$230K 0.01% 797
2020
Q3 		$357K Buy
1,299
+70
+6% +$18.5K 0.01% 885
2020
Q2 		$279K Sell
1,229
-283
-19% -$55.6K 0.01% 875
2020
Q1 		$230K Sell
1,512
-3,911
-72% -$602K 0.01% 899
2019
Q4 		$815K Sell
5,423
-1,431
-21% -$208K 0.02% 580
2019
Q3 		$972K Sell
6,854
-993
-13% -$137K 0.02% 492
2019
Q2 		$982K Buy
7,847
+1,477
+23% +$174K 0.03% 465
2019
Q1 		$702K Buy
+6,370
New +$663K 0.03% 519

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mercer Global Advisors's WST Position: Q2 2026 in Review

Mercer Global Advisors increased its West Pharmaceutical (WST) stake by 59% in Q2 2026, buying an estimated $1.17M and bringing the position to 10,331 shares worth $3.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Mercer Global Advisors first reported a position in WST in Q1 2019 and has held it in 30 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Mercer Global Advisors held 10,331 shares of West Pharmaceutical worth $3.71M as of Q2 2026.
  • Mercer Global Advisors bought 3,830 West Pharmaceutical shares in Q2 2026, an estimated $1.17M.
  • West Pharmaceutical made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1016 holding.
  • Mercer Global Advisors first reported a position in West Pharmaceutical in Q1 2019 and has held it in 30 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.